Diabetes 52:2675-2683, 2003
© 2003 by the American Diabetes Association, Inc.
Transgenic Neuronal Expression of Proopiomelanocortin Attenuates Hyperphagic Response to Fasting and Reverses Metabolic Impairments in Leptin-Deficient Obese Mice
Tooru M. Mizuno1,2,3,
Kevin A. Kelley1,4,
Giulio M. Pasinetti1,5,
James L. Roberts1, and
Charles V. Mobbs1,2,3
1 Fishberg Center for Neurobiology, Mount Sinai School of Medicine, New York, New York
2 Neurobiology of Aging Laboratories, Mount Sinai School of Medicine, New York, New York
3 Department of Geriatrics, Mount Sinai School of Medicine, New York, New York
4 Department of Molecular, Cellular, and Developmental Biology, Mount Sinai School of Medicine, New York, New York
5 Department of Psychiatry, Mount Sinai School of Medicine, New York, New York
Hypothalamic proopiomelanocortin (POMC) gene expression is reduced in many forms of obesity and diabetes, particularly in those attributable to deficiencies in leptin or its receptor. To assess the functional significance of POMC in mediating metabolic phenotypes associated with leptin deficiency, leptin-deficient mice bearing a transgene expressing the POMC gene under control of the neuron-specific enolase promoter were produced. The POMC transgene attenuated fasting-induced hyperphagia in wild-type mice. Furthermore, the POMC transgene partially reversed obesity, hyperphagia, and hypothermia and effectively normalized hyperglycemia, glucosuria, glucose intolerance, and insulin resistance in leptin-deficient mice. Effects of the POMC transgene on glucose homeostasis were independent of the partial correction of hyperphagia and obesity. Furthermore, the POMC transgene normalized the profile of hepatic and adipose gene expression associated with gluconeogenesis, glucose output, and insulin sensitivity. These results indicate that central POMC is a key modulator of glucose homeostasis and that agonists of POMC products may provide effective therapy in treating impairments in glucose homeostasis when hypothalamic POMC expression is reduced, as occurs with leptin deficiency, hypothalamic damage, and aging.
Address correspondence and reprint requests to Charles V. Mobbs, PhD, Neurobiology of Aging Laboratories, Box 1639, Mount Sinai School of Medicine, 1 Gustave L. Levy Pl., New York, NY 10029. E-mail: charles.mobbs{at}mssm.edu

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. E. Pritchard and A. White
Neuropeptide Processing and Its Impact on Melanocortin Pathways
Endocrinology,
September 1, 2007;
148(9):
4201 - 4207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lee, A. Kim, S. C. Chua Jr., S. Obici, and S. L. Wardlaw
Transgenic MSH overexpression attenuates the metabolic effects of a high-fat diet
Am J Physiol Endocrinol Metab,
July 1, 2007;
293(1):
E121 - E131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shimizu, K. Inoue, and M. Mori
The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure
J. Endocrinol.,
April 1, 2007;
193(1):
1 - 9.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-j. Yang, J. Mastaitis, T. Mizuno, and C. V. Mobbs
Glucokinase Regulates Reproductive Function, Glucocorticoid Secretion, Food Intake, and Hypothalamic Gene Expression
Endocrinology,
April 1, 2007;
148(4):
1928 - 1932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Watson, S. Hahm, T. M. Mizuno, J. Windsor, C. Montgomery, P. E. Scherer, C. V. Mobbs, and S. R. J. Salton
VGF Ablation Blocks the Development of Hyperinsulinemia and Hyperglycemia in Several Mouse Models of Obesity
Endocrinology,
December 1, 2005;
146(12):
5151 - 5163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. McMinn, S.-M. Liu, H. Liu, I. Dragatsis, P. Dietrich, T. Ludwig, C. N. Boozer, and S. C. Chua Jr.
Neuronal deletion of Lepr elicits diabesity in mice without affecting cold tolerance or fertility
Am J Physiol Endocrinol Metab,
September 1, 2005;
289(3):
E403 - E411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Coll, B. G. Challis, M. Lopez, S. Piper, G. S.H. Yeo, and S. O'Rahilly
Proopiomelanocortin-Deficient Mice Are Hypersensitive to the Adverse Metabolic Effects of Glucocorticoids
Diabetes,
August 1, 2005;
54(8):
2269 - 2276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cai, S. A Cole, R. A Bastarrachea-Sosa, J. W MacCluer, J. Blangero, and A. G Comuzzie
Quantitative trait locus determining dietary macronutrient intakes is located on human chromosome 2p22
Am. J. Clinical Nutrition,
November 1, 2004;
80(5):
1410 - 1414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Savontaus, T. L. Breen, A. Kim, L. M. Yang, S. C. Chua Jr., and S. L. Wardlaw
Metabolic Effects of Transgenic Melanocyte-Stimulating Hormone Overexpression in Lean and Obese Mice
Endocrinology,
August 1, 2004;
145(8):
3881 - 3891.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Mizuno, I-W. Shu, H. Makimura, and C. Mobbs
Obesity Over the Life Course
Sci. Aging Knowl. Environ.,
June 16, 2004;
2004(24):
re4 - re4.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Genetically Modified Animals in Endocrinology
Endocr. Rev.,
June 1, 2004;
25(3):
512 - 519.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|